X0407 4 2023-05-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001192591 HOMCY CHARLES J C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250 PALO ALTO CA 94304 1 0 0 0 0 Common Stock 2023-05-16 4 M 0 3759 A 1222127 D Common Stock 2023-05-16 4 F 0 1300 14.09 D 1220827 D Restricted Stock Units 2023-05-16 4 M 0 3759 0.00 D Common Stock 3759 11280 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,759 shares of Common Stock underlying the Reporting Person's RSUs. The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. /s/ Brian C. Stephenson, Attorney-in-Fact 2023-05-18